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Abstract: Drug-resistant epilepsy can sometimes be treated by surgery. In these cases, an 
accurate identiﬁ  cation of the epileptogenic area must be addressed before resection. Ictal 
SPECT is one of the presurgical evaluations that can be performed, but usually, the increase 
in the regional cerebral perfusion observed is produced by diffusion of ictal activity. Here we 
describe a patient studied with v-EEG and foramen ovale electrodes that suffered a seizure 
after intravenous infusion of etomidate. The sequence of etomidate administration, followed 
by radiotracer and seizure was good enough for us to suspect that a true initial ictal SPECT was 
observed. We have implemented a kinetic model with four compartments, previously described 
(Andersen 1989), in order to estimate the fraction of hydrophilic radiotracer in the brain during 
the pre-ictal and ictal periods. This model has shown that the fraction of hydrophilic radiotracer 
during the seizure into the brain would be between 18.9% and 42.3% of total infused. We show 
the ﬁ  rst true initial ictal SPECT demonstrated by bioelectrical recordings of the brain activity, 
obtained by a correct succession of events and compatible with theoretical data obtained from 
the kinetic model.
Keywords: etomidate, foramen ovale electrodes, mathematical model, temporal lobe epi-
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Introduction
Epilepsy is one of the most common neurological disorders, affecting almost 
0.5%–1.0% of the general population (Theodore et al 2006). Patients usually respond 
well to pharmacological treatment. However, approximately, 25%–30% of patients 
are drug-resistant (Engel 1996a). For this group, surgery can be a suitable therapeutic 
option (Engel 1992, 1996b; Wiebe et al 2001). Surgical treatment requires an exhaus-
tive presurgical evaluation in order to identify the epileptogenic area and minimize 
the side effects of the operation. Presurgical evaluation usually includes, among 
others (Pastor et al 2005; Sola et al 2005), electroencephalography (EEG), video-
electroencephalography (v-EEG), magnetic resonance imaging (MRI) and single 
photon emission computerized tomography (SPECT).
Interictal or basal SPECT is a presurgical study not performed systematically in 
the majority of epilepsy-surgery units because it is affected by a number of draw-
backs that limits its results (Henry and Heertum 2003). In order to overcome these 
problems, some epilepsy-surgery units perform ictal SPECT, in which a radiotracer is 
intravenously administered after a seizure onset is identiﬁ  ed (Spencer et al 2000; Van 
Paessen et al 2000; Henry and Heertum 2003; Cascino et al 2004). Ictal SPECT has 
been shown to be an accurate means of localization of temporal lobe seizures when 
the tracer is injected immediately after the seizure (Catafau 2001; Van Paessen 2004). 
The localizing information was better when the injection was given soon after seizure 
onset (Newton et al 1992; Avery et al 1999; Van Paessen et al 2000).
Sometimes, during v-EEG recording and in order to increase the probability of 
seizures, pharmacologically induced stimulation has been performed using different Neuropsychiatric Disease and Treatment 2008:4(1) 306
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drugs; ie, clonidine, metohexital, etc (Kofke et al 1993; 
Brockhaus et al 1997; Schmitt et al 1999). Among these, 
the use of etomidate, a nonbarbiturate hypnotic, short-lived 
imidazol derivate, has been rare (Ebrahim et al 1986; Modica 
et al 1990).
In the Hospital La Princesa, currently, we are characterizing 
the response to etomidate in patients with mesial temporal 
lobe epilepsy (MTLE) and undergoing evaluation for surgery 
while they are monitored with v-EEG using foramen ovale 
electrodes (FOE). It is not our objective to describe this 
method in detail (see Dominguez-Gadea et al 2006), but 
to show a fortunate result obtained in the context of that 
study, describing the case of a patient that suffered a seizure 
during etomidate infusion after the radiotracer injection for 
activated SPECT. This allowed us to obtain that which is, to 
our knowledge, the ﬁ  rst true initial ictal SPECT (recorded 
during the true beginning of the seizure and not during the 
propagated ictal activity) described in the literature. We 
have implemented a numerical model previously published 
(Andersen 1989) for the analysis and discussion.
Case report
A 14-year-old, right handed girl with a diagnosis of refractory 
temporal lobe epilepsy (TLE) was referred to the Epilepsy 
Unit, Hospital Universitario “La Princesa”, Madrid, Spain 
for evaluation and surgical treatment of epilepsy.
Pregnancy and birth were normal. No familial epilepsy his-
tory was reported. Seizures began at age 2 years, after a viral 
vaccination. Nowadays, she complains of daily seizures.
Previously tried anti-epileptic drugs (AED) included 
phenitoin, carbamacepine, etosuximide, zonisapride, and 
levetiracetam. At the present time pharmacological treatment 
included (mg/d): topiramate 300; oxcarbamazepine 1500; 
valproate 600; and clobazam 10.
Methods
Presurgical evaluation, following the previously described La 
Princesa Hospital protocol (Pastor et al 2005; Sola et al 2005), 
included neurological and neuropsychological examinations, 
scalp EEG (Nihon Kohden®) with 19 electrodes according 
the 10–20 international system, 1.5 T magnetic resonance 
imaging (MRI; General Electric®) and interictal single 
photon emission computerized tomography (SPECT, General 
Electric®) with 99mTc-D,L-Hexamethylene-propyleneamine 
oxime (99mTc-HmPAO) and video-electroencephalography 
(v-EEG; Easy II Cadwell®) using 19 scalp electrodes and 
foramen ovale electrodes (Pastor et al 2006) removing AED 
from the second to day of recording.
This research was approved by the Ethical Committee of 
the Hospital la Princesa and informed consent was obtained 
from the parents because the patient was under 18 years.
SPECT imaging studies were performed using 740 MBq 
of 99mTc-HmPAO, with a low-energy high-resolution collima-
tor, simple-head camera (Starcam 3200, General Electric®) 
and 96 projections of 22 s each using a 64 × 64 matrix. Slices 
were reconstructed by ﬁ  ltered back projection using a But-
terworth ﬁ  lter (order 10 with a 0.6 cut-off).
V-EEG recording was performed with a bandwidth 
of 1–70 Hz for scalp electrodes and 1–100 Hz for FOE 
recording, with a sampling rate of 200 Hz.
Etomidate (Janssen-Cilag®) was intravenously applied 
in the resting condition, with the patient resting in bed, face 
up, under continuous supervision of an expert anesthesi-
ologist at a dose of 0.1 mg/kg. Perfusion was performed in 
approximately 1 min. Electrocardiogram and capillary oxy-
gen saturation (pulsioximetry) were continuously monitored 
throughout the process. Immediately after the etomidate infu-
sion, a bolus of 99mTc-HmPAO was intravenously injected. 
Brain SPECT was acquired in the 30 min after the complete 
recovery of the patient.
Kinetic model
To analyze the theoretical kinetic behavior of 99mTc-HmPAO, 
we used a numerical model including four compartments 
(see Figure 2B) and four parameters (Andersen 1989). It is 
important to keep in mind that the kinetic parameters are taken 
from biological data, but not adjusted for our patient. The basic 
assumption was that 99mTc-HMPAO behaves according to the 
microsphere model and exhibits high rate extraction (76%) by 
the brain tissue during the ﬁ  rst microcirculatory pass (Lassen 
et al 1988). Numerical solutions of the model were obtained 
by developing a home-made program using the Runge-Kutta 
method for solving differential equations, implemented in 
MATLAB R2007a (MathWorks, Natic, USA) and running 
on a personal computer (Pentium IV, 1 Gb RAM).
Results
The scalp EEG showed the presence of frequent right tem-
poral sharp waves, usually grouped in patterns, intermingled 
with irregular slow waves. MRI was normal and interictal 
SPECT showed inconclusive results, with left temporal 
antero-mesial hypoperfusion doubtful.
Etomidate was intravenously applied by an anesthesiologist 
(MLM) whereas the patient stayed in the v-EEG monitoring 
unit. Ten seconds later, 99mTc-HmPAO was iv perfused (LD-G) 
in order to obtain a pharmacologically activated SPECT. Fifty Neuropsychiatric Disease and Treatment 2008:4(1) 307
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two seconds after 99mTc-HmPAO injection, a seizure begun 
with head version to left, followed by left arm hypertony, 
oral automatisms and mild disconnection. Fifty-two seconds 
thereafter, the seizure ﬁ  nished and the patient recovered con-
sciousness. No stupor or paralysis was observed, but a mild 
disorientation and agitation persisted for 25 seconds.
v-EEG recording showed a beta/gamma low voltage pat-
tern in the right posterior mesial area (right FO electrodes #1 
to #3), as we can observe in Figure 1. A focal desynchroni-
zation was observed in the right temporo-occipital area of 
the scalp.
Injection of the radiotracer began immediately after 
etomidate and 52 sec. before a seizure started. A localized 
region of intense hyperperfusion was observed only in the 
right posterior mesial temporal lobe (Figure 2A, arrow). This 
region ﬁ  ts well with right FOE 1–3, which were involved in 
the origin of the seizure. No changes were observed in other 
regions compared with interictal SPECT performed after a 
24-h seizure-free period.
The numeric simulation of the model (see Figure 2C) 
showed that, in theory, at least, the hydrophilic brain con-
centration at the beginning of the seizure was approximately 
18.9% of the total radiotracer injected, with only 36.6% 
remaining lipophilic in the blood. At the conclusion of the 
seizure, the theoretical brain hydrophilic concentration was 
42.3% and only 15.3% of the radio-tracer persisted in its 
lipophilic form in the blood. This implies that practically all 
the available 99mTc-HmPAO had been extracted by the end of 
seizure. Of course, we are conscious that these results only 
show the compatibility between the theoretical model and 
the time course of events observed in our patient.
Discussion
This paper is the first report of an instance where the 
authors have knowledge of a true-early ictal SPECT, with 
the radiotracer injection performed at an adequate instant, 
demonstrated by means of bioelectrical recording.
An intense increase in regional cerebral blood ﬂ  ow is one 
of the hallmarks of partial-onset seizures. This is probably 
due to an increase in regional synaptic activity and changes 
in neurotransmission. Usually, the 99mTc-HMPAO infusion 
is performed brieﬂ  y after the seizure starts and, moreover, 
a delay must be overcome before the radiotracer gets to the 
brain. So, ictal SPECT, although it is the most sensitive and 
reliable neuroimaging procedure for delineating the epilep-
togenic area in patients with medically intractable epilepsy 
(Bernal and Altman 2003), probably shows an increase in 
regional cerebral perfusion that is surely related to the seizure 
(Van Paesschen 2004), but is almost certainly indicating 
propagation from the area of ictal onset.
Figure 1 Recording of v-EEG during administration of etomidate and the subsequent seizure observed. Discontinuous arrow marks the end of etomidate infusion. 
Continuous arrow shows the 99mTc-HmPAO infusion. Arrowhead indicates the start of seizure and double arrowhead marks the end of it.
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Figure 2 SPECT results and mathematical model of blood-brain 99mTc-HmPAO distribution. A) Basal (left) and etomidate-activated (right) SPECT recordings. The arrow 
shows the hyperperfusion on the right temporo-occipital area (around fusiform and lingual gyri) that corresponds to the most occipital FO electrodes. B) Kinetic model for 
numerical solution of distribution for lipophilic and hydrophilic 99mTc-HmPAO in blood and brain, according to a four-compartment model. The ﬁ  rst-order rate constants are 
(min−1) k1 = 0.81; k2 = 0.35; k3 = 0.92 and k4 = 0.25 -Andersen 1989; C) Kinetic evolution of the model during the ﬁ  rst 3.5 min after 99mTc-HmPAO iv perfusion that shows 
the distribution in the different compartments; the broken-blue line represents the evolution of intracellular hydrophilic radio-tracer. The ﬁ  rst arrow (from left) marks the 
start of seizure and the second one indicates the end.
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What is more important, if the delay between seizure 
onset and injection is big enough, a false lateralization or 
localization on ictal SPECT due to the “postictal switch” 
phenomenon can be observed (Newton et al 1992). Thus, the 
early injection of radiotracer has been considered the most 
important factor for seizure localization.
Taking into account that a majority of the radiotracer 
will be taken up in the ﬁ  rst pass and that it takes around 30 
seconds for the tracer to reach the brain, we can reasonably 
assume that a small amount of the ligand ( 19%) probably 
would be absorbed previous to the seizure onset (pre-ictal 
state). However, as we can observe from Figure 2C, the most 
important amount of radiotracer will be taken up by the brain 
during the seizure (period between both arrows).
The safest and most reproducible way to control the 
moment of injection could be through the use of a pharmaco-
logical activation of the seizures. However, this possibility is 
far from being ready to use (Diekman et al 1998; Kirchberger 
et al 1998). In the model that we are developing in order to 
overcome that problem, the infusion of etomidate induces 
important changes in the cerebral regional perfusion, but 
usually with no associated seizures (Domínguez-Gadea et al 
2007). Indeed, this case was the only one presenting a crisis 
out of 46 patients.
In summary, we are conscious that the case reported here 
was a lucky occurrence, in which the correct order of events 
allowed to us to demonstrate that an increase in regional 
cerebral perfusion would be produced in the cerebral area 
that started the seizure. The systematic methodology in 
pharmacological activated SPECT with etomidate could 
produce reproducible and consistent results even without 
pharmacologically activated seizures. However, more studies 
are needed before this point will be deﬁ  nitely established.
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